View Author
Kaam, A.H. van
( A.H. van Kaam)
surfactant dex treatment treatment group fluid lavaged bal fluid fibroblast study animal patient level ventilation pneumonia lavage proliferation saline effect growth infant surfactant-olc alveolar exogenous surfactant atelectasi pdgf-bb number pressure translocation dexamethasone respir factor lung disease distress syndrome fibrosis bronchoalveolar lavage fluid bal fluid mitogenicity 0.005 blood lavaged group ppvcon 0.05 bronchoalveolar platelet-derived growth factor collagen il -1b levels macrophage volume pdgf-bb levels alveolar macrophages activity lachmann fibroblast proliferation bronchopulmonary dysplasia synthesis mitogenic mitogenic activity fluid-induced table lung lavage exogenou collagen synthesis function ventilator-induced lung injury lachmann b piiinp disease surfactant treatment bronchoalveolar lavage lavaged animals ppvolc blood stream ventilation period period syndrome injury infection reduction decrease distress lung concept
2 Most Recent Publications
|
Reducing atelectasis attenuates bacterial growth and translocation in experimental pneumonia.
(Article)
Kaam, A.H. van Lachmann, R.A. Herting, E. Jaegere, A.P.M.C. de Iwaarden, F. van Noorduyn, L.A. Kok, J.H. Haitsma, J.J. Lachmann, B.F. |
2004-01-01
|
|
Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity
(Article)
Dik, W.A. Versnel, M.A. Naber, B.A. Janssen, D.J. Kaam, A.H. van Zimmermann, L.J.I. |
2003-01-01
|